Can mtDNA Mutations be Used as Biomarkers for Cancer?
Yes, mtDNA mutations have the potential to serve as biomarkers for cancer. Certain mutations are found more frequently in specific types of cancer, making them useful for diagnosis and prognosis. Additionally, because mtDNA is present in high copy numbers in cells, it can be easily detected in bodily fluids, offering a non-invasive method for cancer monitoring.
